US 7956177
dsRNA compositions and methods for treating HPV infection
granted A61PA61P31/12A61P31/18
Quick answer
US patent 7956177 (dsRNA compositions and methods for treating HPV infection) held by Alnylam Pharmaceuticals, Inc. expires Mon Jun 02 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Jun 07 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 02 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61P, A61P31/12, A61P31/18, A61P31/20